Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    0.87
    -0.07 (-7.94%)
    At close: Aug 15, 2025, 1:22 PM

    Prelude Therapeutics Revenue

    Prelude Therapeutics reported an annual revenue of $7M, reflecting a 0% growth. For the quarter ending March 31, 2025, Prelude Therapeutics generated $0 in revenue.
    Revenue (ttm)
    7M
    Revenue Growth
    n/a
    Price / Sales Ratio
    13.75
    Revenue / Employee
    53.44K
    Employees
    131
    Market Cap
    48.22M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist